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Integrating clinicopathological and molecular data in the breast cancer patient 
Towards precision medicine 
1. Immunoediting generates breast tumors capable of immune escape, which leads to cancer 
progression and worse clinical outcomes (This thesis)
2. Breast tumor IGF1 receptor status has proven a promising marker for the treatment of hor-
mone receptor positive breast cancer patients. Time will tell whether it will also be of great 
value in the aging cancer population due to the mild adverse events of metformin treatment 
(This thesis)
3. The dual role of HIF-1 in both cancer and aging may explain why the greatest risk of cancer 
is age (This thesis)
4. TNM staging does not provide an optimal prognostic and treatment decision-making-model 
and therefore should be complemented with tumor (bio)-markers and patient characteris-
tics to achieve personalized treatment (This thesis)
5. To provide the most adequate breast cancer treatment per individual, the practitioner 
should loosen the reins on strict guidelines, moving further away from the “one-size-fits-all” 
concept and strive for tailored treatment 
6. It is argued that an inventory of feedback and crosstalk circuits between signaling pathways 
will be instrumental in finding the right drug combinations for each individual patient. Our 
lack of understanding of the way in which signaling networks interconnect represents a 
critical missing link in realizing the ultimate goal of personalized medicine (Bernards R, Cell. 
2012 Oct 26;151(3):465-8)
7. If age-related metabolic changes are an early driver of tumorigenesis, molecules that prevent 
and reverse metabolic aging may be useful as cancer therapies. Given the key role of sirtuins 
in tumorigenesis, it is feasible that lifestyle interventions and small molecules that activate 
sirtuins could induce a youthful metabolic state and serve to prevent and treat cancer (Wu 
LE, Cancer Cell. 2014 Jan 13;25(1):12-9)
8. Surgical oncology, medical oncology and radiation oncology, also known as “the big three” 
players in (breast) cancer treatment will soon become “the big four”, as the interventional 
radiologist is progressively becoming the treating physician of choice for patients who are 
less suitable candidates for surgery
9. The good thing about science is that it’s true whether or not you believe in it (Neill deGrasse 
Tyson, Twitter, 2013)
10. In science we abide by: ‘Quod gratis asseritur, gratis negatur‘(Anonymous)
11. Het hospitaal is een noodzakelijk kwaad, hoe meer men er buiten houdt hoe beter het eraan 
toe gaat (Dr. C.J.H.Engels)
12. No guts, no glory (Major Gen. Frederick C. Blesse, fighter tactics book US Airforce, 1955)
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